UniProt ID | CAVN1_HUMAN | |
---|---|---|
UniProt AC | Q6NZI2 | |
Protein Name | Caveolae-associated protein 1 {ECO:0000312|HGNC:HGNC:9688} | |
Gene Name | CAVIN1 {ECO:0000312|HGNC:HGNC:9688} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 390 | |
Subcellular Localization | Membrane, caveola . Cell membrane . Microsome . Endoplasmic reticulum . Cytoplasm, cytosol . Mitochondrion . Nucleus . Translocates to the cytoplasm from the caveolae upon insulin stimulation (PubMed:17026959). Colocalizes with CAV1 in lipid rafts in | |
Protein Description | Plays an important role in caveolae formation and organization. Essential for the formation of caveolae in all tissues. [PubMed: 18056712] | |
Protein Sequence | MEDPTLYIVERPLPGYPDAEAPEPSSAGAQAAEEPSGAGSEELIKSDQVNGVLVLSLLDKIIGAVDQIQLTQAQLEERQAEMEGAVQSIQGELSKLGKAHATTSNTVSKLLEKVRKVSVNVKTVRGSLERQAGQIKKLEVNEAELLRRRNFKVMIYQDEVKLPAKLSISKSLKESEALPEKEGEELGEGERPEEDAAALELSSDEAVEVEEVIEESRAERIKRSGLRRVDDFKKAFSKEKMEKTKVRTRENLEKTRLKTKENLEKTRHTLEKRMNKLGTRLVPAERREKLKTSRDKLRKSFTPDHVVYARSKTAVYKVPPFTFHVKKIREGQVEVLKATEMVEVGADDDEGGAERGEAGDLRRGSSPDVHALLEITEESDAVLVDKSDSD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEDPTLYI -------CCCCCEEE | 15242332 | ||
5 | Phosphorylation | ---MEDPTLYIVERP ---CCCCCEEEEECC | 20639409 | ||
7 | Phosphorylation | -MEDPTLYIVERPLP -CCCCCEEEEECCCC | 25106551 | ||
16 | Phosphorylation | VERPLPGYPDAEAPE EECCCCCCCCCCCCC | 20639409 | ||
25 | Phosphorylation | DAEAPEPSSAGAQAA CCCCCCCCCHHHHCC | 26657352 | ||
26 | Phosphorylation | AEAPEPSSAGAQAAE CCCCCCCCHHHHCCC | 26657352 | ||
36 | Phosphorylation | AQAAEEPSGAGSEEL HHCCCCCCCCCCHHH | 29255136 | ||
40 | Phosphorylation | EEPSGAGSEELIKSD CCCCCCCCHHHHHHC | 29255136 | ||
46 | Phosphorylation | GSEELIKSDQVNGVL CCHHHHHHCCCCCEE | 22777824 | ||
50 (in isoform 3) | Ubiquitination | - | 21890473 | ||
53 (in isoform 3) | Ubiquitination | - | 21890473 | ||
56 | Phosphorylation | VNGVLVLSLLDKIIG CCCEEHHHHHHHHHH | 22199227 | ||
60 | Ubiquitination | LVLSLLDKIIGAVDQ EHHHHHHHHHHHHHH | 22817900 | ||
64 (in isoform 3) | Ubiquitination | - | 21890473 | ||
68 (in isoform 3) | Ubiquitination | - | 21890473 | ||
77 (in isoform 3) | Ubiquitination | - | 21890473 | ||
82 | Sulfoxidation | LEERQAEMEGAVQSI HHHHHHHHHHHHHHH | 30846556 | ||
88 | Phosphorylation | EMEGAVQSIQGELSK HHHHHHHHHHHHHHH | 26657352 | ||
88 (in isoform 2) | Phosphorylation | - | 21902226 | ||
92 (in isoform 3) | Ubiquitination | - | 21890473 | ||
94 | Phosphorylation | QSIQGELSKLGKAHA HHHHHHHHHHCCCCC | 27251275 | ||
95 | Ubiquitination | SIQGELSKLGKAHAT HHHHHHHHHCCCCCC | 23000965 | ||
95 (in isoform 1) | Ubiquitination | - | 21890473 | ||
98 | Ubiquitination | GELSKLGKAHATTSN HHHHHHCCCCCCCHH | 23000965 | ||
98 (in isoform 1) | Ubiquitination | - | 21890473 | ||
102 | Phosphorylation | KLGKAHATTSNTVSK HHCCCCCCCHHHHHH | 23403867 | ||
103 | Phosphorylation | LGKAHATTSNTVSKL HCCCCCCCHHHHHHH | 23403867 | ||
104 | Phosphorylation | GKAHATTSNTVSKLL CCCCCCCHHHHHHHH | 23403867 | ||
106 | Phosphorylation | AHATTSNTVSKLLEK CCCCCHHHHHHHHHH | 21406692 | ||
107 (in isoform 3) | Ubiquitination | - | 21890473 | ||
108 | Phosphorylation | ATTSNTVSKLLEKVR CCCHHHHHHHHHHHH | 23403867 | ||
109 | Acetylation | TTSNTVSKLLEKVRK CCHHHHHHHHHHHHC | 23236377 | ||
109 | Malonylation | TTSNTVSKLLEKVRK CCHHHHHHHHHHHHC | 26320211 | ||
109 | Ubiquitination | TTSNTVSKLLEKVRK CCHHHHHHHHHHHHC | 23000965 | ||
109 (in isoform 1) | Ubiquitination | - | 21890473 | ||
113 | Ubiquitination | TVSKLLEKVRKVSVN HHHHHHHHHHCCCCC | 23000965 | ||
113 (in isoform 1) | Ubiquitination | - | 21890473 | ||
116 | Sumoylation | KLLEKVRKVSVNVKT HHHHHHHCCCCCHHH | - | ||
116 | Sumoylation | KLLEKVRKVSVNVKT HHHHHHHCCCCCHHH | 28112733 | ||
116 | Ubiquitination | KLLEKVRKVSVNVKT HHHHHHHCCCCCHHH | 23000965 | ||
116 (in isoform 3) | Ubiquitination | - | 21890473 | ||
118 | Phosphorylation | LEKVRKVSVNVKTVR HHHHHCCCCCHHHHH | 23911959 | ||
120 (in isoform 3) | Ubiquitination | - | 21890473 | ||
122 | Malonylation | RKVSVNVKTVRGSLE HCCCCCHHHHHHHHH | 26320211 | ||
122 | Sumoylation | RKVSVNVKTVRGSLE HCCCCCHHHHHHHHH | 28112733 | ||
122 | Ubiquitination | RKVSVNVKTVRGSLE HCCCCCHHHHHHHHH | 23000965 | ||
122 (in isoform 1) | Ubiquitination | - | 21890473 | ||
123 | Phosphorylation | KVSVNVKTVRGSLER CCCCCHHHHHHHHHH | 20068231 | ||
125 (in isoform 3) | Ubiquitination | - | 21890473 | ||
127 | Phosphorylation | NVKTVRGSLERQAGQ CHHHHHHHHHHHCCC | 28355574 | ||
128 (in isoform 3) | Ubiquitination | - | 21890473 | ||
136 | 2-Hydroxyisobutyrylation | ERQAGQIKKLEVNEA HHHCCCEEEEECCHH | - | ||
136 | Ubiquitination | ERQAGQIKKLEVNEA HHHCCCEEEEECCHH | 23000965 | ||
137 | Malonylation | RQAGQIKKLEVNEAE HHCCCEEEEECCHHH | 26320211 | ||
137 | Ubiquitination | RQAGQIKKLEVNEAE HHCCCEEEEECCHHH | 23000965 | ||
137 (in isoform 1) | Ubiquitination | - | 21890473 | ||
152 | Acetylation | LLRRRNFKVMIYQDE HHHHCCCEEEEEECC | 26051181 | ||
152 | Malonylation | LLRRRNFKVMIYQDE HHHHCCCEEEEEECC | 26320211 | ||
152 | Ubiquitination | LLRRRNFKVMIYQDE HHHHCCCEEEEEECC | 23000965 | ||
152 (in isoform 1) | Ubiquitination | - | 21890473 | ||
154 | Sulfoxidation | RRRNFKVMIYQDEVK HHCCCEEEEEECCCC | 30846556 | ||
156 | Phosphorylation | RNFKVMIYQDEVKLP CCCEEEEEECCCCCC | 21945579 | ||
161 | Sumoylation | MIYQDEVKLPAKLSI EEEECCCCCCCEEEE | - | ||
161 | Acetylation | MIYQDEVKLPAKLSI EEEECCCCCCCEEEE | 26051181 | ||
161 | Malonylation | MIYQDEVKLPAKLSI EEEECCCCCCCEEEE | 26320211 | ||
161 | Sumoylation | MIYQDEVKLPAKLSI EEEECCCCCCCEEEE | 25114211 | ||
161 | Ubiquitination | MIYQDEVKLPAKLSI EEEECCCCCCCEEEE | 23000965 | ||
161 (in isoform 1) | Ubiquitination | - | 21890473 | ||
165 | 2-Hydroxyisobutyrylation | DEVKLPAKLSISKSL CCCCCCCEEEECCCH | - | ||
165 | Acetylation | DEVKLPAKLSISKSL CCCCCCCEEEECCCH | 19813393 | ||
165 | Malonylation | DEVKLPAKLSISKSL CCCCCCCEEEECCCH | 26320211 | ||
165 | Sumoylation | DEVKLPAKLSISKSL CCCCCCCEEEECCCH | 28112733 | ||
165 | Ubiquitination | DEVKLPAKLSISKSL CCCCCCCEEEECCCH | 23000965 | ||
165 (in isoform 1) | Ubiquitination | - | 21890473 | ||
167 | Phosphorylation | VKLPAKLSISKSLKE CCCCCEEEECCCHHH | 29255136 | ||
169 | Phosphorylation | LPAKLSISKSLKESE CCCEEEECCCHHHHH | 30266825 | ||
170 | 2-Hydroxyisobutyrylation | PAKLSISKSLKESEA CCEEEECCCHHHHHC | - | ||
170 | Malonylation | PAKLSISKSLKESEA CCEEEECCCHHHHHC | 26320211 | ||
170 | Sumoylation | PAKLSISKSLKESEA CCEEEECCCHHHHHC | 28112733 | ||
170 | Ubiquitination | PAKLSISKSLKESEA CCEEEECCCHHHHHC | 23000965 | ||
170 (in isoform 1) | Ubiquitination | - | 21890473 | ||
171 | Phosphorylation | AKLSISKSLKESEAL CEEEECCCHHHHHCC | 28355574 | ||
173 | Sumoylation | LSISKSLKESEALPE EEECCCHHHHHCCCH | - | ||
173 | Malonylation | LSISKSLKESEALPE EEECCCHHHHHCCCH | 32601280 | ||
173 | Sumoylation | LSISKSLKESEALPE EEECCCHHHHHCCCH | - | ||
173 | Ubiquitination | LSISKSLKESEALPE EEECCCHHHHHCCCH | 23000965 | ||
173 (in isoform 1) | Ubiquitination | - | 21890473 | ||
175 | Phosphorylation | ISKSLKESEALPEKE ECCCHHHHHCCCHHH | 28176443 | ||
181 | Ubiquitination | ESEALPEKEGEELGE HHHCCCHHHCCCCCC | - | ||
202 | Phosphorylation | DAAALELSSDEAVEV HHHHHHCCCCCCEEH | 28176443 | ||
203 | Phosphorylation | AAALELSSDEAVEVE HHHHHCCCCCCEEHH | 28176443 | ||
209 (in isoform 2) | Ubiquitination | - | 21890473 | ||
216 | Phosphorylation | VEEVIEESRAERIKR HHHHHHHHHHHHHHH | 28176443 | ||
227 (in isoform 2) | Ubiquitination | - | 21890473 | ||
233 | Ubiquitination | LRRVDDFKKAFSKEK CCCHHHHHHHHCHHH | 27667366 | ||
237 | Phosphorylation | DDFKKAFSKEKMEKT HHHHHHHCHHHHHHH | 24719451 | ||
238 | Ubiquitination | DFKKAFSKEKMEKTK HHHHHHCHHHHHHHC | 27667366 | ||
244 | O-linked_Glycosylation | SKEKMEKTKVRTREN CHHHHHHHCCCCHHH | 30379171 | ||
254 | 2-Hydroxyisobutyrylation | RTRENLEKTRLKTKE CCHHHHHHHCCHHHH | - | ||
254 | Ubiquitination | RTRENLEKTRLKTKE CCHHHHHHHCCHHHH | 29967540 | ||
258 | Ubiquitination | NLEKTRLKTKENLEK HHHHHCCHHHHHHHH | 33845483 | ||
259 | Phosphorylation | LEKTRLKTKENLEKT HHHHCCHHHHHHHHH | - | ||
260 | Ubiquitination | EKTRLKTKENLEKTR HHHCCHHHHHHHHHH | 33845483 | ||
265 | 2-Hydroxyisobutyrylation | KTKENLEKTRHTLEK HHHHHHHHHHHHHHH | - | ||
265 | Ubiquitination | KTKENLEKTRHTLEK HHHHHHHHHHHHHHH | 33845483 | ||
266 | Phosphorylation | TKENLEKTRHTLEKR HHHHHHHHHHHHHHH | 28176443 | ||
269 | Phosphorylation | NLEKTRHTLEKRMNK HHHHHHHHHHHHHHH | 30576142 | ||
272 | Ubiquitination | KTRHTLEKRMNKLGT HHHHHHHHHHHHHCC | 29967540 | ||
272 (in isoform 3) | Ubiquitination | - | 21890473 | ||
276 | Ubiquitination | TLEKRMNKLGTRLVP HHHHHHHHHCCCCCC | 33845483 | ||
279 | Phosphorylation | KRMNKLGTRLVPAER HHHHHHCCCCCCHHH | 25867546 | ||
296 | Ubiquitination | KLKTSRDKLRKSFTP HHHCCHHHHHHHCCC | 23000965 | ||
299 | 2-Hydroxyisobutyrylation | TSRDKLRKSFTPDHV CCHHHHHHHCCCCCE | - | ||
299 | Acetylation | TSRDKLRKSFTPDHV CCHHHHHHHCCCCCE | 27452117 | ||
299 | Malonylation | TSRDKLRKSFTPDHV CCHHHHHHHCCCCCE | 26320211 | ||
299 | Ubiquitination | TSRDKLRKSFTPDHV CCHHHHHHHCCCCCE | 23000965 | ||
299 (in isoform 1) | Ubiquitination | - | 21890473 | ||
300 | Phosphorylation | SRDKLRKSFTPDHVV CHHHHHHHCCCCCEE | 26846344 | ||
302 | Phosphorylation | DKLRKSFTPDHVVYA HHHHHHCCCCCEEEE | 26846344 | ||
308 | Phosphorylation | FTPDHVVYARSKTAV CCCCCEEEEECCCEE | 25159151 | ||
311 | Phosphorylation | DHVVYARSKTAVYKV CCEEEEECCCEEEEC | 26437602 | ||
312 | Ubiquitination | HVVYARSKTAVYKVP CEEEEECCCEEEECC | 23000965 | ||
313 | Phosphorylation | VVYARSKTAVYKVPP EEEEECCCEEEECCC | 26657352 | ||
316 | Phosphorylation | ARSKTAVYKVPPFTF EECCCEEEECCCCEE | 28152594 | ||
317 | Ubiquitination | RSKTAVYKVPPFTFH ECCCEEEECCCCEEE | 23000965 | ||
317 (in isoform 1) | Ubiquitination | - | 21890473 | ||
326 | 2-Hydroxyisobutyrylation | PPFTFHVKKIREGQV CCCEEEEEECCCCCC | - | ||
326 | Acetylation | PPFTFHVKKIREGQV CCCEEEEEECCCCCC | 30591687 | ||
326 | Sumoylation | PPFTFHVKKIREGQV CCCEEEEEECCCCCC | 28112733 | ||
326 | Ubiquitination | PPFTFHVKKIREGQV CCCEEEEEECCCCCC | 32015554 | ||
327 | Acetylation | PFTFHVKKIREGQVE CCEEEEEECCCCCCE | 30591693 | ||
337 | Ubiquitination | EGQVEVLKATEMVEV CCCCEEEEEEEEEEE | - | ||
341 | Sulfoxidation | EVLKATEMVEVGADD EEEEEEEEEEECCCC | 28465586 | ||
365 | Phosphorylation | AGDLRRGSSPDVHAL CCCCCCCCCCCHHHH | 30266825 | ||
366 | Phosphorylation | GDLRRGSSPDVHALL CCCCCCCCCCHHHHH | 30266825 | ||
376 | Phosphorylation | VHALLEITEESDAVL HHHHHHCCCCCCCEE | 30266825 | ||
379 | Phosphorylation | LLEITEESDAVLVDK HHHCCCCCCCEEEEC | 30266825 | ||
387 | Phosphorylation | DAVLVDKSDSD---- CCEEEECCCCC---- | 30266825 | ||
389 | Phosphorylation | VLVDKSDSD------ EEEECCCCC------ | 30266825 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
300 | S | Phosphorylation | Kinase | AURKB | Q96GD4 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CAVN1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CAVN1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ZN148_HUMAN | ZNF148 | physical | 10727401 | |
TFF1_HUMAN | TFF1 | physical | 9582279 | |
TRI72_HUMAN | TRIM72 | physical | 21343302 | |
TF3C4_HUMAN | GTF3C4 | physical | 22939629 | |
TMEDA_HUMAN | TMED10 | physical | 22939629 | |
RS4X_HUMAN | RPS4X | physical | 22939629 | |
LIPS_HUMAN | LIPE | physical | 17026959 | |
MAGI3_HUMAN | MAGI3 | physical | 28514442 | |
M21D2_HUMAN | MB21D2 | physical | 28514442 | |
MD1L1_HUMAN | MAD1L1 | physical | 28514442 | |
ZBTB1_HUMAN | ZBTB1 | physical | 28514442 | |
ZN622_HUMAN | ZNF622 | physical | 28514442 | |
FHL2_HUMAN | FHL2 | physical | 28514442 | |
ZZEF1_HUMAN | ZZEF1 | physical | 28514442 | |
UTRO_HUMAN | UTRN | physical | 28514442 | |
FBX28_HUMAN | FBXO28 | physical | 28514442 | |
TRI26_HUMAN | TRIM26 | physical | 28514442 | |
TERF2_HUMAN | TERF2 | physical | 28514442 | |
HECD3_HUMAN | HECTD3 | physical | 28514442 | |
KLH15_HUMAN | KLHL15 | physical | 28514442 | |
SNTB2_HUMAN | SNTB2 | physical | 28514442 | |
OBSL1_HUMAN | OBSL1 | physical | 28514442 | |
CRBN_HUMAN | CRBN | physical | 28514442 | |
HSP7C_HUMAN | HSPA8 | physical | 28514442 | |
EXOC7_HUMAN | EXOC7 | physical | 28514442 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...